Zypan is Standard Process's anchor digestive enzyme product and one of the few SP products where dose-titration to a patient-specific endpoint matters more than following a label. The combination — betaine HCl, pepsin, pancreatin — targets the two most common digestive complaints in adult patients: hypochlorhydria (low stomach acid) and reduced pancreatic enzyme output. The titration protocol is straightforward, the contraindications are sharp, and the clinical wins are real. This piece walks through how to prescribe Zypan correctly, when to choose it over Multizyme or Lact-Enz, and the screening every prescriber should run first.
Zypan — Clinical Quick Reference
- Start: 1 tablet with the largest meal
- Titrate up by 1 tablet/meal until slight warm sensation; back off by 1
- Typical clinical doses: 1-4 tablets per meal
- Take mid-meal, not pre-meal
- Hard contraindications: active PUD, gastritis, NSAID use, untreated H. pylori, corticosteroid use
- For patients on PPIs who can't take HCl: substitute Multizyme
The formulation — three layers of digestive support
Zypan's three components target sequential phases of protein digestion.
Betaine HCl. Hydrochloric acid in betaine-bound form, designed to release HCl in the stomach to support protein denaturation. This is the component that requires the titration protocol and carries the contraindications. Age-related hypochlorhydria (decreased stomach acid production with age, particularly after 50) is more common than most patients or practitioners realize.
Pepsin. The gastric protease enzyme that cleaves protein bonds in the acidic stomach environment. Pepsin requires HCl to function; supplementing pepsin without sufficient HCl produces minimal benefit.
Pancreatin. A broad-spectrum pancreatic enzyme complex (protease, amylase, lipase) supporting the small-intestinal digestive phase after the stomach. This addresses the secondary pattern of reduced pancreatic enzyme output that frequently accompanies chronic hypochlorhydria.
The titration protocol — finding the patient's HCl ceiling
Unlike most SP products where the dose is fixed and clinically validated, Zypan dosing is patient-specific. The titration is the prescribing protocol.
Day 1. 1 tablet mid-meal with the largest meal of the day (typically dinner). Patient observes for the next 30-60 minutes for any warm or burning sensation in the stomach.
Day 2-3. If no warm sensation occurred, increase to 2 tablets with the same meal. If a slight warm sensation occurred, hold at 1 — that's the patient's endpoint.
Day 4-7. Continue titrating up by 1 tablet per meal until the patient reports a clear (but not painful) warm sensation in the stomach. That's the indicator the patient has reached HCl repletion for that meal size.
Maintenance. Back off by 1 tablet from the endpoint. Settle into the steady dose for routine meals; increase by 1 for larger or protein-heavy meals; decrease by 1 for smaller or low-protein meals.
Most adult patients land in the 1-3 tablets per meal range. Patients with severe hypochlorhydria can require 4-5 per meal initially, then titrate down as gastric function recovers.
The contraindications that every prescriber should screen for
Zypan's HCl content makes it inappropriate for patients with already-irritated gastric mucosa. The screening is mechanistic and should be explicit before prescribing.
Active peptic ulcer disease. Adding HCl to an ulcerated stomach worsens the ulcer. Hard contraindication until the ulcer is healed.
Active gastritis. Same mechanism. Treat the gastritis first; reconsider Zypan after resolution.
Current NSAID use. Regular ibuprofen, aspirin, naproxen — any NSAID at frequent dosing. NSAIDs damage the gastric mucosa; adding HCl compounds the damage. Patients on occasional NSAID use (1-2 doses/month for a headache) can take Zypan with caution; patients on daily NSAID protocols cannot.
Untreated H. pylori. H. pylori colonization is exacerbated by HCl supplementation. Test for and treat H. pylori before prescribing Zypan.
Current corticosteroid use. Prednisone and similar steroids increase gastric ulcer risk; combining with HCl is unwise.
Zypan vs. Multizyme vs. Lact-Enz — the prescribing decision tree
Three SP digestive products that often get confused.
Zypan — hypochlorhydria + reduced enzyme output. Most common adult presentation: post-meal bloating within 30 minutes, fullness from small portions, undigested food in stool, sense of "food sitting heavy." Adult patients over 50 with these symptoms are often Zypan candidates.
Multizyme — enzyme insufficiency without active HCl issue. The right pick for patients on PPIs who can't take HCl supplementation, or for patients whose digestive complaints localize to the small intestine rather than the stomach (post-meal gas/bloating 1-2 hours after eating, rather than immediate fullness).
Lact-Enz — lactose intolerance specifically. Lactase enzyme supplementation for patients who tolerate other foods but have GI distress with dairy. Take 1-2 capsules immediately before consuming dairy.
58-year-old patient, post-meal bloating, B12 deficiency without GI surgery
A 58-year-old patient presents with 18 months of progressively worse post-meal bloating, fullness from small portions, and recent labs showing B12 deficiency (245 pg/mL) without prior gastric surgery or known absorption disorder. PPI use: none. NSAID use: occasional (2-3x monthly).
Clinical pattern: age-related hypochlorhydria producing both the bloating symptoms and the B12 deficiency (HCl is required for B12 cleaving from food proteins). Zypan was prescribed with the standard titration: 1 tablet at dinner day 1; up to 2 at dinner + 1 at lunch by day 4; up to 2 at lunch + 3 at dinner by day 8 (the patient's first warm-sensation endpoint at the larger evening meal); settled at 2 with lunch, 2 with dinner for steady state.
At 60 days: post-meal bloating substantially improved; portion size returned to normal. At 90-day labs: B12 recovered to 480 pg/mL (foundational B-complex added to support, but the HCl repletion was the primary driver). Patient continues Zypan as long-term replacement therapy for age-related hypochlorhydria.
Common mistakes
Five anti-patterns in Zypan prescribing
- Skipping the titration. Prescribing "1 tablet 3x daily" without titrating misses both under-dosed and over-dosed patients.
- Not screening for contraindications. The 5 hard contraindications (PUD, gastritis, NSAID, H. pylori, corticosteroids) should be explicit screening questions before prescribing.
- Confusing Zypan with Multizyme. The HCl difference matters. PPI patients need Multizyme, not Zypan.
- Taking pre-meal instead of mid-meal. The HCl works during the meal; pre-meal dosing reduces effectiveness.
- Stopping Zypan when symptoms resolve without retesting. Some patients recover gastric function; others don't. Trial a dose reduction at 6 months; if symptoms return, the patient needs long-term replacement therapy.
Frequently asked questions
What's in Zypan and what does each ingredient do?
Betaine HCl (stomach acid support), pepsin (gastric protease for protein digestion), and pancreatin (pancreatic enzymes for small-intestinal digestion). Targets hypochlorhydria + reduced pancreatic enzyme output.
How do I titrate Zypan to the patient's optimal dose?
Start at 1 tablet with the largest meal. Titrate up by 1 tablet per meal until the patient feels a slight warm sensation — that's the HCl repletion endpoint. Back off by 1. Typical doses: 1-4 tablets per meal.
What are the contraindications for Zypan?
Active peptic ulcer disease, active gastritis, current NSAID use, untreated H. pylori, and corticosteroid use. Screen explicitly before prescribing.
Zypan vs. Multizyme vs. Lact-Enz — when does each apply?
Zypan: hypochlorhydria + reduced enzyme output (most common adult presentation). Multizyme: enzyme insufficiency without HCl issue (right for PPI patients). Lact-Enz: lactose intolerance, lactase supplementation for dairy meals.
How do I screen for hypochlorhydria before prescribing Zypan?
Clinical signs: post-meal bloating within 30 minutes, fullness from small portions, undigested food in stool, B12 deficiency without GI surgery, age over 60, chronic PPI use. Trial-of-Zypan with titration functions as diagnostic + therapeutic.
Can patients take Zypan long-term?
Yes, for chronic hypochlorhydria. Re-evaluate at 6 months — if symptoms stay resolved with reduced dose, gastric function may be recovering. Otherwise long-term replacement therapy is appropriate.
Where to go next
Three companion pieces: Designs for Health GI-Resolve vs. SP for intestinal mucosa support, SP vs. Metagenics for gut barrier integrity, and the foundational stack that supports digestive function broadly. Supplement Practice's AI Co-Pilot includes the Zypan titration protocol as a default template when hypochlorhydria signals are present in the intake.
